From Medscape Gastroenterology

Coverage from the

European Crohn's and Colitis Organisation (ECCO) 2023 Congress

March 01 - 04, 2023; Copenhagen, Denmark/Virtual

March 01 - 04, 2023 Copenhagen, Denmark/Virtual

ECCO 2023 Upadacitinib Shows Positive Endoscopic Outcomes in Crohn's Disease Already FDA approved for ulcerative colitis, upadacitinib improves endoscopic response versus placebo in people with Crohn's disease, research shows.
Medscape Medical News, March 16, 2023
ECCO 2023 Nearly 1 in 3 Patients With IBD Affected by Skin Lesions No significant difference was found in skin lesion prevalence between patients with ulcerative colitis and Crohn's disease.
Medscape Medical News, March 9, 2023
ECCO 2023 Mental Health Risks Higher Among Young People With IBD Beyond anxiety and depression, researchers report children and young adults with inflammatory bowel disease are at higher risk for developing a wide range of mental health disorders.
Medscape Medical News, March 6, 2023

Conference News

ECCO 2023 Have IBD and Insomnia? You're Not Alone
WebMD Health News, March 16, 2023
ECCO 2023 Upadacitinib Shows Positive Endoscopic Outcomes in Crohn's Disease
Medscape Medical News, March 16, 2023
ECCO 2023 Crohn's Disease Remission Rates Higher With Vedolizumab: Study
MDedge News, March 9, 2023
ECCO 2023 Nearly 1 in 3 Patients With IBD Affected by Skin Lesions
Medscape Medical News, March 9, 2023
ECCO 2023 AI-Assisted Colonoscopy in IBD: Not All It's Cut Out to Be?
Medscape Medical News, March 7, 2023
ECCO 2023 Mental Health Risks Higher Among Young People With IBD
Medscape Medical News, March 6, 2023

ECCO 2023 Ileocecal Resection Possible First-line Option in Early Crohn's
MDedge News, March 6, 2023
ECCO 2023 Pediatric IBD Patients Wrestle With Lingering Gut Pain
MDedge News, March 6, 2023
ECCO 2023 IBD: More Patients on Vedolizumab vs Anti-TNFs at 2 Years
MDedge News, March 3, 2023
ECCO 2023 DNA Panels Could Predict Endoscopic Response to Biologics in CD
Medscape Medical News, March 3, 2023
ECCO 2023 Cannabis Tied to Lower IBD Mortality, Hospital Costs
MDedge News, March 3, 2023

Medscape Gastroenterology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Popular News From ECCO 2022

Upadacitinib Reduces Extraintestinal Manifestations of UC: Study Researchers evaluated phase 3 data comparing the oral JAK inhibitor with placebo for treating anemia, peripheral arthropathy, axial arthropathy, and other extraintestinal manifestations.
Medscape Medical News, Feb 28, 2022
Two Studies Shed Light on IBD Treatment After Anti-TNF Failure Separate studies compared vedolizumab with tofacitinib in ulcerative colitis and to ustekinumab in Crohn's disease.
Medscape Medical News, Feb 24, 2022
Meta-Analysis Favors SubQ Infliximab Over Vedolizumab in Crohn's Researchers evaluated results of seven major studies to compare efficacy and safety of the two agents in Crohn's disease and ulcerative colitis.
Medscape Medical News, Feb 23, 2022

Previous Coverage

ECCO 2022

Related Resource

Inflammatory Bowel Disease News & Perspectives